zanosar 1 g
esteve pharmaceuticals s.a.s. - streptozocin - pulver til konsentrat til infusjonsvæske, oppløsning - 1 g
mayzent
novartis europharm limited - siponimod fumaric syre - multippel sklerose, relapsing-remitting - selektive immunosuppressiva - mayzent er indisert for behandling av voksne pasienter med sekundær progressiv multippel sklerose (spms) med aktiv sykdom dokumentert ved tilbakefall eller bildebehandling funksjoner av inflammatorisk aktivitet.
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurias - andre alimentary tract and metabolism products, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
vyepti
h. lundbeck a/s - eptinezumab - migrene lidelser - analgetika - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - multippelt myelom - antineoplastiske midler - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
sitagliptin/metformin glenmark 50 mg / 850 mg
glenmark arzneimittel gmbh - sitagliptinhydrokloridmonohydrat / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 850 mg
sitagliptin/metformin glenmark 50 mg / 1000 mg
glenmark arzneimittel gmbh - sitagliptinhydrokloridmonohydrat / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 1000 mg
sitagliptin/metformin medical valley 50 mg / 850 mg
medical valley invest ab - sitagliptinhydroklorid / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 850 mg
sitagliptin/metformin medical valley 50 mg / 1000 mg
medical valley invest ab - sitagliptinhydroklorid / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 1000 mg
sapropterin teva 100 mg
teva gmbh - sapropterindihydroklorid - oppløselig tablett - 100 mg